Principal
Ariel Kantor, Ph.D.
Background
Ariel is a scientist, entrepreneur, and company builder. Prior to joining Versant, he held several leadership roles at ReCode therapeutics, most recently serving as Chief Business Officer. Earlier, he served as an Entrepreneur-in-Residence at Oxford Science Enterprises, launching and financing multiple Oxford spinouts, and worked as an investment banker at Evercore Partners advising on corporate strategy, M&A, and capital markets transactions.
Dr. Kantor has co-founded several companies in the fields of genetic medicines and RNA biology and has been recognized by honors such as Forbes 30 Under 30 and the San Francisco Business Times 40 under 40.
History
Ariel graduated summa cum laude from Duke University with a B.S. in bioengineering and finance and received his Ph.D. in Clinical Neuroscience from the University of Oxford, where he was a Rhodes Scholar.